Advanced search
Publication Cover
Hematology Volume 26, 2021 - Issue 1
Submit an article Journal homepage
1,831
Views
10
CrossRef citations to date
0
Altmetric
Articles

Association of coagulation disturbances with severity of COVID-19: a longitudinal study

Huimin Lua Department of Intensive Care Unit, Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital, Nanjing, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-3638-2963View further author information
ORCID Icon,
Ming Chena Department of Intensive Care Unit, Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital, Nanjing, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-1627-6189View further author information
ORCID Icon,
Shaoqiu Tangb Department of General Practice, Nanjing University Hospital, Nanjing, People’s Republic of ChinaView further author information
&
Wenkui Yua Department of Intensive Care Unit, Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital, Nanjing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 656-662 | Published online: 07 Sep 2021

References

  • van der Poll T, Herwald H. The coagulation system and its function in early immune defense. Thromb Haemost. 2014;112(4):640–648.
  • Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
  • Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemostasis. 2020;18(4):844–847.
  • Castelli R, Gidaro A. Abnormal hemostatic parameters and risk of thromboembolism among patients with COVID-19 infection. Journal of Hematology. 2020;9(1-2):1–4.
  • Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.
  • National Health Commission & National Administration of Traditional Chinese Medicine 2020. Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7). Chin Med J 2020;133(9):1087–1095.
  • Bi X, Su Z, Yan H, et al. Prediction of severe illness due to COVID-19 based on an analysis of initial fibrinogen to albumin ratio and platelet count. Platelets. 2020;31(5):674–679.
  • Hardy M, Michaux I, Lessire S, et al. Prothrombotic hemostasis disturbances in patients with severe COVID-19: individual daily data. Data Brief. 2020;33:106519.
  • Hardy M, Michaux I, Lessire S, et al. Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study. Thromb Res. 2021;197:20–23.
  • Hardy M, Lecompte T, Douxfils J, et al. Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory. Thromb J. 2020;18:17.
  • Kampouri E, Filippidis P, Viala B, et al. Predicting venous thromboembolic events in patients with coronavirus disease 2019 requiring hospitalization: an observational retrospective study by the COVIDIC initiative in a Swiss University hospital. Biomed Res Int. 2020;2020: 9126148.
  • Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834–847.
  • Nougier C, Benoit R, Simon M, et al. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis. J Thromb Haemost. 2020;18(9):2215–2219.
  • Iba T, Levy JH, Levi M, et al. Coagulopathy in COVID-19. J Thromb Haemost. 2020;18(9):2103–2109.
  • Liu J, Li S, Liu J, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55:102763.
  • Vallet B, Wiel E. Endothelial cell dysfunction and coagulation. Crit Care Med. 2001;29(7 Suppl):S36–S41.
  • Witkowski M, Landmesser U, Rauch U. Tissue factor as a link between inflammation and coagulation. Trends Cardiovasc Med. 2016;26(4):297–303.
  • Keller TT, Mairuhu ATA, de Kruif MD, et al. Infections and endothelial cells. Cardiovasc Res. 2003;60(1):40–48.
  • Kowalczuk S, Bröer A, Tietze N, et al. A protein complex in the brush-border membrane explains a hartnup disorder allele. FASEB J. 2008;22(8):2880–2887.
  • Silver MA, Bohnert M, Beck AT, et al. Relation of depression of attempted suicide and seriousness of intent. Arch Gen Psychiatry. 1971;25(6):573–576.
  • Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11(8):875–879.
  • Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450–454.
  • Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418.
  • Teijaro JR, Walsh KB, Cahalan S, et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell. 2011;146(6):980–991.
  • Wang J, Saguner AM, An J, et al. Dysfunctional coagulation in COVID-19: from cell to bedside. Adv Ther. 2020;37(7):3033–3039.
  • Guervilly C, Burtey S, Sabatier F, et al. Circulating endothelial cells as a marker of endothelial injury in severe COVID-19. J Infect Dis. 2020;222(11):1789–1793.
  • Grobler C, Maphumulo SC, Grobbelaar LM, et al. Covid-19: The rollercoaster of fibrin(ogen), D-dimer, Von willebrand factor, P-selectin and their interactions with endothelial cells, platelets and erythrocytes. Int J Mol Sci. 2020;21(14):5168.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.